Frontiers in Pharmacology | Renal Pharmacology

Review

Published on 20 Apr 2022

Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities

in Renal Pharmacology

Zhumei Gao
Xiangmei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.805281

8,856 views
36 citations

Original Research

Published on 19 Apr 2022

Anti-Apoptosis of Podocytes and Pro-Apoptosis of Mesangial Cells for Telmisartan in Alleviating Diabetic Kidney Injury

in Renal Pharmacology

Xin Wei
Yabin Ma
Ya Li
Wenzhao Zhang
Yuting Zhong
Yue Yu
Li-Chao Zhang
Zhibin Wang
Ye Tu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.876469

2,832 views
3 citations

Review

Published on 19 Apr 2022

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials

in Renal Pharmacology

Qi Feng
Xiaoyue Yu
Yingjin Qiao
Shaokang Pan
Rui Wang
Bin Zheng
Hui Wang
Kai-Di Ren
Hui Liu
Yang Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.858676

19,182 views
81 citations

Original Research

Published on 14 Apr 2022

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease

in Renal Pharmacology

Bo Zhang
Yuzhou Wan
Xuefeng Zhou
Haojun Zhang
Hailing Zhao
Liang Ma
Xi Dong
Meihua Yan
Tingting Zhao
Ping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.872988

8,671 views
38 citations

Original Research

Published on 12 Apr 2022

Maslinic Acid Attenuates Ischemia/Reperfusion-Induced Acute Kidney Injury by Suppressing Inflammation and Apoptosis Through Inhibiting NF-κB and MAPK Signaling Pathway

in Renal Pharmacology

Wenjuan Sun
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Soo Wan Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2022.807452

4,398 views
23 citations

Correction

Published on 31 Mar 2022

Corrigendum: The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

in Renal Pharmacology

Ming-Hsien Tsai
Mingchih Chen
Yen-Chun Huang
Hung-Hsiang Liou
Yu-Wei Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.894462

1,021 views
2 citations

Original Research

Published on 29 Mar 2022

A Human Conditionally Immortalized Proximal Tubule Epithelial Cell Line as a Novel Model for Studying Senescence and Response to Senolytics

in Renal Pharmacology

Yi Yang
Milos Mihajlovic
Floris Valentijn
Tri Q. Nguyen
Roel Goldschmeding
Rosalinde Masereeuw

Frontiers in Pharmacology

doi 10.3389/fphar.2022.791612

5,255 views
11 citations

Original Research

Published on 24 Mar 2022

Fraxin Promotes the Activation of Nrf2/ARE Pathway via Increasing the Expression of Connexin43 to Ameliorate Diabetic Renal Fibrosis

in Renal Pharmacology

Rui Chen
Jingran Zeng
Chuting Li
Haiming Xiao
Shanshan Li
Zeyuan Lin
Kaipeng Huang
Juan Shen
Heqing Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.853383

2,851 views
10 citations

Systematic Review

Published on 24 Mar 2022

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis

in Renal Pharmacology

Xiao-Yong Yu
Qian Sun
Ya-Mei Zhang
Liang Zou
Ying-Yong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.860588

11,465 views
85 citations

Original Research

Published on 24 Mar 2022

Salvia miltiorrhiza Bunge (Danshen) and Bioactive Compound Tanshinone IIA Alleviates Cisplatin-Induced Acute Kidney Injury Through Regulating PXR/NF-κB Signaling

in Renal Pharmacology

Jing-Yun Dou
Min Zhang
Huan Cen
Yi-Qin Chen
Yi-Fan Wu
Fuhua Lu
Jiuyao Zhou
Xu-Sheng Liu
Yue-Yu Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.860383

4,674 views
20 citations

Original Research

Published on 23 Mar 2022

Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies

in Renal Pharmacology

Ruonan Zhai
Yuan Liu
Jiahao Tong
Ying Yu
Lin Yang
Yong Gu
Jianying Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.826792

5,975 views
14 citations

Original Research

Published on 21 Mar 2022

Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis

in Renal Pharmacology

Kam Wa Chan
Kam Yan Yu
Wai Han Yiu
Rui Xue
Sarah Wing-yan Lok
Hongyu Li
Yixin Zou
Jinyuan Ma
Kar Neng Lai
Sydney Chi-wai Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.794139

8,217 views
13 citations

Original Research

Published on 18 Mar 2022

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome

in Renal Pharmacology

Cankun Zheng
Wanling Xuan
Zhenhuan Chen
Rui Zhang
Xiaoxia Huang
Yingqi Zhu
Siyuan Ma
Kaitong Chen
Lu Chen
Mingyuan He

Frontiers in Pharmacology

doi 10.3389/fphar.2022.848310

4,847 views
17 citations

Original Research

Published on 18 Mar 2022

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis

in Renal Pharmacology

Lu-Yun Qin
Peng Guan
Jian-Xin Wang
Yu Chen
Ya-Shuo Zhao
Sheng-Chang Yang
Ya-Jing Guo
Na Wang
En-Sheng Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2022.812594

6,029 views
25 citations

Original Research

Published on 18 Mar 2022

Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis

in Renal Pharmacology

Mei-Zi Wang
Jie Wang
Dong-Wei Cao
Yue Tu
Bu-Hui Liu
Can-Can Yuan
Huan Li
Qi-Jun Fang
Jia-Xin Chen
Yan Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.790937

8,277 views
48 citations

Review

Published on 18 Mar 2022

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease

in Renal Pharmacology

Yinghui Huang
Wang Xin
Jiachuan Xiong
Mengying Yao
Bo Zhang
Jinghong Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.837500

12,558 views
54 citations